United States · 
What does Gilead Sciences invest in?
Gilead Sciences invests most often at Series B and Series A (100% of the rounds on record), in sectors such as Biopharma, Hiv and Liver Disease.
Gilead Sciences highlights
- 01
3 rounds on record
- 02
Mostly Series B and Series A: 100% of its rounds
What they do
Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer & inflammation.From their own website
- Type
- Company
- Cheque size
- Not stated
- Stages
- GrowthSeries B
- Sectors
- BiopharmaHivLiver Disease
- Based in
- Foster City, United States
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first3 appearances
- 2019
1 round
- Jan
- 2018
2 rounds
- Oct
- Jun
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Companies it bought
Acquisitions by the firm itself
Epitherapeutics$65MMay 2015
Phenex Pharmaceuticals$470MJan 2015
YM BioSciencesUndisclosedFeb 2013
Pharmasset$11BNov 2011
Calistoga Pharmaceuticals$375MFeb 2011
Arresto BioSciences$225MDec 2010
CGI Pharmaceuticals$120MJun 2010
Corus PharmaUndisclosedOct 2006
MyogenUndisclosedOct 2006